News
Myeloma Trial Results Spark Talk of 'Potential Cure' — One-third of patients alive and progression-free 5 or more years after a single infusion ...
Roche is to buy gene therapy firm Spark Therapeutics for $4.8 billion, adding an already-approved treatment for inherited blindness to its portfolio, and boosting its pipeline with a series of ...
Spark New Zealand Limited (SPK), an ASX-listed company, operates as a telecommunications service provider in New Zealand, catering to both consumer and business segments. The company is organized into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results